IN8bio, Inc. (INAB)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20260 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to IN8bio, Inc.’s names, not what it holds today.
5 published
2 published
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Dec 18, 2025 | 2025/0381221 | Compositions and Methods for Treating Cancer | Pharmaceuticals | IN8bio, Inc. |
| Oct 9, 2025 | 2025/0313803 | Compositions and Methods for Cancer Immunotherapy | Pharmaceuticals | IN8bio, Inc. |
| Mar 27, 2025 | 2025/0099585 | IPSC-Based Gamma-Delta T-Cells, Compositions and Methods of Use Thereof | Medical technology | IN8bio, Inc. |
| Aug 18, 2022 | 2022/0259768 | MULTIVALENT CHLOROTOXIN CHIMERIC ANTIGEN RECEPTORS | Biotechnology | IN8bio, Inc. |
| Oct 21, 2021 | 2021/0322475 | COMPOSITIONS AND METHODS FOR TREATING CANCER | Pharmaceuticals | IN8bio, Inc. |
| Jun 18, 2020 | 2020/0188436 | Compositions and Methods for Cancer Immunotherapy | Pharmaceuticals | Incysus Therapeutics, Inc. |
| Dec 19, 2019 | 2019/0381100 | Compositions and Methods for Cancer Immunotherapy | Pharmaceuticals | Incysus Therapeutics, Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.